Dr. James Milton Parker, MD

Dr. Parker practices at Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery.

Dr. Parker's NPI, 1407888555, was assigned on July 7, 2006. Dr. Parker graduated from Louisiana State University School of Medicine in New Orleans in 2004. Dr. Parker holds Louisiana license 200635.

Dr. Parker's primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery, at 8100 South Walker Bldg C, Oklahoma City, OK 73139 in Oklahoma County. The practice phone is (405) 602-6500.

Dr. Parker's primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery. Dr. Parker is also affiliated with North Oaks Medical Center. The medical group on file is North Oaks Medical Center. Dmand AI also links Dr. Parker to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parker practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Parker's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Parker is licensed in Louisiana.

CMS data shows 4,811 Medicare services from Dr. Parker across 28 procedure codes in 2024, for 1,455 Medicare patients. Medicare paid $159,752 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,455 Medicare patients who saw Dr. Parker in 2024. The largest group is 65 to 74, with 614 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parker's median patient age at 65, with 55% women.

In 2024, Dr. Parker wrote 11,449 Medicare Part D claims for 1,180 patients. 75% of them were for generic drugs. CMS names the drug for 11,057 of them, across 88 drugs with 11 or more claims each, at $2,210,344 in total drug cost. In 2023, CMS named 12,802 claims across 93 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Parker for performance year 2024, reported as part of a group. Dr. Parker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 40 procedures of coronary angioplasty and stenting by Dr. Parker, more than 76% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Parker, published from 2013 to 2019. 2013 was the busiest year, with 3. The most frequent topics are Cells, Cultured, Induced Pluripotent Stem Cells and Accidents, Traffic. Dr. Parker has published most often in Accid Anal Prev. Dr. Parker's most frequent co-authors are Stuart A. Lipton, MD, PhD, Eliezer Masliah, MD and Matthew Brenner, MD.

CMS Open Payments shows 244 general payments to Dr. Parker from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Abbott Laboratories paid the most, $1,757.

Dr. Parker graduated from Louisiana State University School of Medicine in New Orleans in 2004.